Sun Pharmaceutical Industries informs about press release

21 Jun 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma signing a non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1720.00 0.40 (0.02%)
31-Dec-2025 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1271.00
Cipla 1501.95
Zydus Lifesciences 913.50
Lupin 2104.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×